A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
Status:
Completed
Trial end date:
2009-12-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the acceptability and safety of Suboxone in heroin
users as a replacement therapy for opioid dependency by comparing the clinical response of
participants who are inducted directly onto Suboxone with that of participants who are
inducted first to Subutex and then transferred to Suboxone.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Heroin